Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-27 2:05 pm Purchase | 2024-02-14 | 13G | Azitra, Inc. AZTR | LYTTON LAURENCE W | 369,985 5.800% | 369,985 (New Position) | Filing History |
| 2024-02-14 6:48 pm Sale | 2023-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP | LYTTON LAURENCE W | 11,900 0.100% | -113,129 (-90.48%) | Filing History |
| 2024-02-14 3:28 pm Purchase | 2023-12-31 | 13G | Scientific Industries, Inc. SCND | LYTTON LAURENCE W | 1,083,899 9.990% | 689,220 (+174.63%) | Filing History |
| 2024-02-14 3:23 pm Purchase | 2023-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | LYTTON LAURENCE W | 109,339 9.990% | 46,504 (+74.01%) | Filing History |
| 2024-02-14 2:42 pm Purchase | 2023-12-31 | 13G | Exagen Inc. XGN | LYTTON LAURENCE W | 1,153,488 6.800% | 282,307 (+32.41%) | Filing History |
| 2024-02-14 2:35 pm Purchase | 2023-12-31 | 13G | Stryve Foods, Inc. SNAX | LYTTON LAURENCE W | 194,780 8.900% | 194,780 (New Position) | Filing History |
| 2024-02-14 2:27 pm Purchase | 2023-12-31 | 13G | Societal CDMO, Inc. SCTL | LYTTON LAURENCE W | 10,340,858 9.900% | 3,847,168 (+59.24%) | Filing History |
| 2024-02-14 2:22 pm Purchase | 2023-12-31 | 13G | Rail Vision Ltd. RVSN | LYTTON LAURENCE W | 450,000 9.300% | 252,500 (+127.85%) | Filing History |
| 2024-02-14 2:09 pm Purchase | 2023-12-31 | 13G | RingCentral, Inc. RNG | LYTTON LAURENCE W | 1,528,157 1.800% | 1,528,157 (New Position) | Filing History |
| 2024-02-14 2:03 pm Purchase | 2023-12-31 | 13G | Molecular Templates, Inc. MTEM | LYTTON LAURENCE W | 232,951 4.300% | 232,951 (New Position) | Filing History |
| 2024-02-14 1:59 pm Sale | 2023-12-31 | 13G | Miromatrix Medical Inc. MIRO | LYTTON LAURENCE W | 0 0.000% | -1,380,367 (Position Closed) | Filing History |
| 2024-02-14 1:49 pm Purchase | 2023-12-31 | 13G | LiqTech International, Inc. LIQT | LYTTON LAURENCE W | 589,653 9.990% | 589,653 (New Position) | Filing History |
| 2024-02-14 1:43 pm Sale | 2023-12-31 | 13G | aTyr Pharma, Inc. ATYR | LYTTON LAURENCE W | 585,013 1.000% | -3,855,175 (-86.82%) | Filing History |
| 2024-02-14 1:36 pm Purchase | 2023-12-31 | 13G | Giga-tronics Incorporated GIGA | LYTTON LAURENCE W | 608,177 9.990% | 4,477 (+0.74%) | Filing History |
| 2024-02-14 1:31 pm Purchase | 2023-12-31 | 13G | EMCORE Corporation EMKR | LYTTON LAURENCE W | 778,733 9.990% | 486,406 (+166.39%) | Filing History |
| 2024-02-14 1:23 pm Sale | 2023-12-31 | 13G | Duos Technologies Group, Inc. DUOT | LYTTON LAURENCE W | 482,976 6.700% | -151,049 (-23.82%) | Filing History |
| 2024-02-14 1:18 pm Unchanged | 2023-12-31 | 13G | Gyre Therapeutics, Inc. GYRE | LYTTON LAURENCE W | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-14 1:10 pm Purchase | 2023-12-31 | 13G | BIOLASE INC PAR $.001 BIOLQ | LYTTON LAURENCE W | 26,824 0.600% | 26,824 (New Position) | Filing History |
| 2024-02-14 1:05 pm Sale | 2023-12-31 | 13G | Alimera Sciences, Inc. ALIM | LYTTON LAURENCE W | 2,185,364 4.200% | -799,439 (-26.78%) | Filing History |
| 2024-01-11 1:04 pm Purchase | 2023-12-28 | 13G | NeuroOne Medical Technologies Corporation NMTC | LYTTON LAURENCE W | 1,304,102 5.200% | 1,304,102 (New Position) | Filing History |